Insulet PODD International — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Insulet's international — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Insulet's international — revenue?
- Insulet (PODD) reported international — revenue of $242.9M in Q1 2026.
- How has Insulet's international — revenue changed year-over-year?
- Insulet's international — revenue increased by 59.5% year-over-year, from $152.3M to $242.9M.
- What is the long-term trend for Insulet's international — revenue?
- Over 4 years (2021 to 2025), Insulet's international — revenue has grown at a 20.3% compound annual growth rate (CAGR), from $359.9M to $754.3M.
- What does international — revenue mean?
- Total sales generated from products sold in markets outside the company's home country.
- How do you interpret international — revenue?
- An increase indicates successful market penetration and adoption of the product in international territories, while a decrease may signal competitive pressure or regulatory hurdles in those regions.
- How does international — revenue compare across companies?
- Comparable to international segment revenue reported by other global medical device manufacturers, often adjusted for currency fluctuations.